Reflecting $SWP.TO Swiss Water’s optimistic outlook, the company filed notice of intention to launch a Normal Course Issuer Bid (NCIB) to repurchase its shares. #ConsumerTrends #BeverageIndustry buff.ly/UJbMzF2

$RERE Secondary Smartphone Market Remains Resilient Amid Industry Headwinds #recycling #preowned buff.ly/4XGuKMZ

$ACHV Sopharma Wants In #biotech #quitsmoking buff.ly/gdTdNq9

$AMS is focused on strengthening its balance sheet; believe insider liquidity in extension supports positive outlook #healthcare #technology buff.ly/XkuK7b8

$HITI: High Tide Continues to Outperform Canadian Cannabis Industry #CannabisRetailGrowth #CannabisStocks buff.ly/TNVN9rq

$IXRRF Ionic Rare Earths’ Outlook Is for Strong, Profitable Growth as Commercial Operations Commence at the Belfast Recycling Plant in 2028 #rareearthoxides #smallcaps buff.ly/xON1pa3

$COCP New CEO for Cocrystal #antiviral #investing buff.ly/DUDJHr1

$CING Distribution Deal with Prasco Signed #smallcaps #biopharma buff.ly/bRb8PJk

$GXAI Strong Q2 Top-Line Beat, Gaming Asset Sale, and Raised 2026 Outlook Offset by Dilution Risks #GenerativeAI #TechGrowth buff.ly/Q0J30E9

$BSIN Big Sky Industrial Updates Business Developments for Montana Properties and Announces 2nd Quarter 2026 Results #MarketExpansion #SustainableEnergy buff.ly/sBNqkNy

$RVPH Patent Filed for New Brilaroxazine Formulation #NeuroInnovation #BioTech buff.ly/tINzsSt

Extraordinary Growth at $PRE Continues #ClinicalTrials #BiotechInnovation buff.ly/73USLQ7

$ABEO NTAP Status for Zevaskyn Starting Oct. 1, 2026 #biotech #genetherapy buff.ly/zJsfh1c

$BBLG in Good Position as Trials Progress #backpain #medtech buff.ly/OU9NLbv

$KBSX FST Corp Reports Solid 2nd Quarter 2026 Financial Results #SportsTech #PerformanceGolf buff.ly/qNkf03c

$CTSO CytoSorbents Expects to File a New De Novo Application for DrugSorb-ATR in early 2027 #medtech #immunotherapy buff.ly/r68FsDt

$IMNN Increased Enrollment Rate for OVATION 3 Trial #vaccines #DNA buff.ly/onq2R1n

$CRDF Minor Survival Update for CRDF-004 #Oncology #ClinicalTrials buff.ly/OYx45HB

$COSM Posts Record Revenues #pharmaceutical #DigitalHealth buff.ly/o5kF9vm